Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Patients”

59,509 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59,509 results

Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)WithdrawnNCT05279859
What this trial is testing

Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
Erasca, Inc.
Not applicableStudy completedNCT01716559
What this trial is testing

An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy

Who this might be right for
Anemia
Hoffmann-La Roche 160
Early research (Phase 1)Study completedNCT03934359
What this trial is testing

Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai De Novo Pharmatech Co., Ltd. 19
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Not applicableUnknownNCT04563780
What this trial is testing

The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 113
Early research (Phase 1)UnknownNCT04448379
What this trial is testing

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc. 48
Early research (Phase 1)Study completedNCT00575562
What this trial is testing

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Early research (Phase 1)Study completedNCT00085488
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center
Not applicableStudy completedNCT03453788
What this trial is testing

Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology

Who this might be right for
Gynecologic Cancer
Sorlandet Hospital HF 24
Not applicableStudy completedNCT05809661
What this trial is testing

Implementation of the Nurse Navigation Program

Who this might be right for
Intestinal Cancer
Kilis 7 Aralik University 58
Not applicableLooking for participantsNCT07474142
What this trial is testing

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Who this might be right for
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital 1,000
Early research (Phase 1)Study completedNCT00003742
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00312442
What this trial is testing

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Who this might be right for
Prostate Cancer
STEBA France 16
Not applicableStudy completedNCT04190342
What this trial is testing

Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients

Who this might be right for
Breast Neoplasm FemaleSymptom ClusterTai ji
Charles Darwin University 72
Not applicableStudy completedNCT00934986
What this trial is testing

Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Institut Paoli-Calmettes 70
Testing effectiveness (Phase 2)UnknownNCT05885386
What this trial is testing

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

Who this might be right for
PheochromocytomaParaganglioma
Peking Union Medical College Hospital 20
Next Page